BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17695438)

  • 1. Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix.
    Kokawa K; Nishimura R; Fujii T; Umesaki N
    Anticancer Res; 2007; 27(4C):2721-7. PubMed ID: 17695438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study.
    Umesaki N; Fujii T; Nishimura R; Tanaka T; Nishida M; Fushiki H; Takizawa K; Yamamoto K; Hasegawa K; Izumi R;
    Gynecol Oncol; 2004 Oct; 95(1):127-32. PubMed ID: 15385121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Sugiyama T; Nishida T; Kumagai S; Nishio S; Fujiyoshi K; Okura N; Yakushiji M; Hiura M; Umesaki N
    Br J Cancer; 1999 Sep; 81(1):95-8. PubMed ID: 10487618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
    Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
    Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
    Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of irinotecan combined with mitomycin-C and 5-fluorouracil for gynecological malignancies: the JGOG study.
    Kokawa K; Umesaki N; Yamamoto K; Takizawa K; Konishi I; Hasegawa K;
    Anticancer Res; 2008; 28(5B):2933-9. PubMed ID: 19031936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemotherapy with irinotecan and mitomycin for FIGO stage IIIb cervical squamous cell carcinoma: a pilot study.
    Tanaka T; Kokawa K; Umesaki N
    Eur J Gynaecol Oncol; 2005; 26(6):605-7. PubMed ID: 16398218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer.
    Yamao T; Shirao K; Matsumura Y; Muro K; Yamada Y; Goto M; Chin K; Shimada Y
    Ann Oncol; 2001 Dec; 12(12):1729-35. PubMed ID: 11843251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
    Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
    Shoji T; Takatori E; Furutake Y; Takada A; Nagasawa T; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T
    Int J Clin Oncol; 2016 Dec; 21(6):1120-1127. PubMed ID: 27342833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified shortened administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer.
    Ren Y; Li Y; Liu J
    Int J Gynecol Cancer; 2011 May; 21(4):685-9. PubMed ID: 21543932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
    Abou-Taleb HA; Koshiyama M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Abiko K; Yamanoi K; Murakami R; Horikawa N; Taha AA; Kitamura S; Konishi I
    J Int Med Res; 2016 Apr; 44(2):346-56. PubMed ID: 26831404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer.
    Raspagliesi F; Ditto A; Selvaggi L; Frigerio L; Melpignano M; Scambia G; Apolloni C; Scollo P; Pignata S; Panici PB
    Int J Gynecol Cancer; 2010 Dec; 20(9):1569-75. PubMed ID: 21119370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study.
    Fukuda M; Soda H; Fukuda M; Kinoshita A; Nakamura Y; Nagashima S; Takatani H; Tsukamoto K; Kohno S; Oka M
    Cancer; 2007 Aug; 110(3):606-13. PubMed ID: 17577234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
    Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
    Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma.
    Nishino K; Aoki Y; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2005 Jun; 97(3):893-7. PubMed ID: 15894369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
    Leon O; Guren MG; Radu C; Gunnlaugsson A; Johnsson A
    Eur J Cancer; 2015 Dec; 51(18):2740-6. PubMed ID: 26597443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.